Carl Soranno

Carl Soranno came to the practice of law following a 10-year career in finance, securities, and investment banking. Carl has combined that experience with 27 years as a multidisciplinary commercial litigator which has shaped him into a formidable litigator and trial attorney, Carl has litigated well over 1,000 large and small actions, including disputes related to complex family matters, child custody, commercial transactions, contracts between debtors and creditors, commercial lending/workouts, foreclosure, bankruptcy, trademark infringement, consumer fraud, employment, shareholder claims, restrictive covenant claims, and tort-related actions.

New Jersey

New Jersey Courts

ID Number: 009901993

Member and Chair, Family Law Services

Brach Eichler

2009 - Current

Mr. Soranno is a senior member of the business litigation and intellectual property groups and chairs the family law practice group. Mr. Soranno's practice is devoted to representing and counseling business and individual clients assisting them with their various litigation needs, including family law, bankruptcy litigation and business workouts. For over 30 years, Mr. Soranno has handled hundreds of complex business disputes for his clients. Mr. Soranno also directs the family law practice group of the firm and is an accomplished family law attorney representing clients in all areas of matrimonial litigation. He brings a wealth of litigation experience and accomplished business skills to his family practice using those skills to effectively represent his clients especially in matters concerning the valuation and distribution of assets, custody and support.

Co-Founder; Corporate Secretary (2009-2015); Board of Directors (2009-2011)

Edge Therapeutics, Inc.

2009 - 2015

Mr. Soranno is a co-founder of Edge Therapeutics, which is a hospital-focused biopharmaceutical company that uses a novel, site-specific and sustained release-microparticle technology platform to develop products for acute, and fatal or debilitating neurological conditions that currently have no effective therapies. The company's patent-protected bioabsorbable microparticle formulations release drugs locally and consistently at therapeutic concentrations in the brain, which maximizes therapeutic activity while avoiding treatment-limiting systemic side effects seen with oral and intravenous delivery. The lead product EG-1962 is a microparticle formulation of the calcium channel blocker nimodipine. These drugs are being developed to prevent delayed complications after subarachnoid hemorrhage (where today oral- or i.v.-administered nimodipine is employed but in suboptimal concentrations due to the generation of systemic side effects).

Partner

Wolf Block LLP

2003 - 2009

Member of Business Litigation, Securities, Family Law and Intellectual Property departments. Represented commercial and business clients both counseling and litigating a number of commercial and business disputes, including intellectual property disputes.

Member

Brach Eichler Rosenberg Silver Bernstein Hammer & Gladstone, P.C.

1993 - 2003

Full service law firm specializing in Litigation, Family Law, Real Estate, Health Law, Trust & Estates and Environmental/Land Use. Associate from 1993-1999, Director from 2000-2003, Chair, Family Law Department and senior member of business litigation group.

Summer Associate

Grotta, Glassman & Hoffman

1992 - 1992

Premier Labor & Employment firm specializing in all areas of labor and employment.

Seton Hall University School of Law

J.D. (1995)

1995

New Jersey State Bar  # 009901993

Member

1993 - Current